Panel Discussion |Are AI-Based Technologies Evolving Cardiovascular Patient Engagement?

Monday, March 9, 2026

9:34 AM - 9:50 AM EST

Location: Cabinet

Moderator(s)

Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose
Richard E. Galgon, MD, MS

Principal Consultant
CardioMed Device Consultants, LLC
Waunakee, Wisconsin, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure(s): ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)
Jose M. De La Torre Hernandez, MD, PhD

Interventional Cardiologist, Research Unit
Hospital U. Marques de Valdecilla / IDIVAL
Santander, Spain

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Amgen, Chiesi, Angel/Avertix Medical, Anthos Therapeutics, Janssen Pharmaceuticals, Johnson & Johnson Corporation, Bayer Corporation, Corsear, MashUp MD, Bioclinica, MD Magazine, Boehringer Ingelheim, Merck, Boston Clinical Research Institute, MjHeal: Consulting Fees (e.g., advisory boards) (Ongoing); HeartBeam, nference, Flow Therapy, Celecor, Fortress Biotech, TribeMD (Co-Founder), Generable and Lexaria: Stock Options [in privately held companies] (Ongoing); Johnson & Johnson Corporation, CSL Behring, SCAD Alliance, NACAM Trial (Sub-award - 5R01HL151996-05), and Janssen Pharmaceuticals.: Grant/Research Support (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing)
Semih Oktay, PhD

President
Cardiomed Device Consultants
Annapolis, Maryland, United States

Disclosure(s): Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)
Allen J. Taylor, MD

Chairman of Cardiology
MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Heartflow Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Richard E. Galgon, MD, MS: No financial relationships to disclose

Rafael Beyar, MD, DSc, MPH: ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Jose M. De La Torre Hernandez, MD, PhD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

C. Michael Gibson, MD: Amgen, Chiesi, Angel/Avertix Medical, Anthos Therapeutics, Janssen Pharmaceuticals, Johnson & Johnson Corporation, Bayer Corporation, Corsear, MashUp MD, Bioclinica, MD Magazine, Boehringer Ingelheim, Merck, Boston Clinical Research Institute, MjHeal: Consulting Fees (e.g., advisory boards) (Ongoing); HeartBeam, nference, Flow Therapy, Celecor, Fortress Biotech, TribeMD (Co-Founder), Generable and Lexaria: Stock Options [in privately held companies] (Ongoing); Johnson & Johnson Corporation, CSL Behring, SCAD Alliance, NACAM Trial (Sub-award - 5R01HL151996-05), and Janssen Pharmaceuticals.: Grant/Research Support (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing)

Semih Oktay, PhD: Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)

Allen J. Taylor, MD: Heartflow Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)